Early detection of cardiac ischaemia
Cardiac ischaemia occurs when the blood flow to the heart is reduced often due to atherosclerosis, the formation of cholesterol plaques blocking one of the central arteries. Ischaemia can have serious complications, including heart attacks and the ensuing irreversible damage that can lead to heart failure. To prevent heart damage progression, the EU-funded AGLYC project has developed a first-class blood-based biomarker for early detection of ischaemia before irreversible injury of the heart. The biomarker test will be easy to use, sensitive and cost-effective, and will improve the early diagnosis of ischaemic episodes. Given that cardiovascular diseases are the leading cause of morbidity and mortality worldwide, implementation of the AGLYC biomarker is expected to positively impact patient lives.
Fields of science
Call for proposalSee other projects for this call